According to a recent LinkedIn post from Cleerly, the company is highlighting new upgrades to its platform via a feature called Cleerly PREVIEW. The tool is described as helping care teams prioritize coronary CT angiography studies by visualizing ranges of greatest stenosis, exact diameter stenosis values and locations, and severity thresholds tied to common reimbursement considerations.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests these enhancements are designed to surface clinically relevant information earlier in radiology and cardiology workflows, potentially improving operational efficiency and consistency in decision-making. For investors, this emphasis on workflow integration and reimbursement-aligned insights may strengthen Cleerly’s value proposition with hospitals and imaging centers, supporting adoption and recurring revenue potential in the AI-enabled cardiovascular imaging segment.
By focusing on coronary artery disease severity and decision support, the feature appears to deepen Cleerly’s clinical utility in a competitive AI in healthcare market. If providers view PREVIEW as a tool that can streamline interpretations and align with billing practices, it could enhance customer retention and differentiate Cleerly against other imaging analytics vendors over time.